Ference, Brian A <br/><br/>
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.  [electronic resource] 

 -  JAMA  09 2017 
 - 947-956 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.2017.11467  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--therapeutic use<br/>Apolipoproteins B--blood<br/>Cardiovascular Diseases--genetics<br/>Cholesterol Ester Transfer Proteins--antagonists & inhibitors<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Female<br/>Genetic Variation<br/>Humans<br/>Hydroxymethylglutaryl CoA Reductases--genetics<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypercholesterolemia--blood<br/>Male<br/>Mendelian Randomization Analysis<br/>Middle Aged<br/>Risk Factors